Cobalt Challenges Patents For AstraZeneca's Crestor
Cobalt Pharmaceuticals Inc. is seeking U.S. regulatory approval to make and sell a generic version of Astrazeneca PLC's cholesterol drug Crestor, claiming that two patents for the drug, which had U.S....To view the full article, register now.
Already a subscriber? Click here to view full article